Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 6,887 shares at $26.20 ($177K) on 2015-04-27, disclosed to the SEC on 2015-04-29.
Scheduled sale ($177k) by SVP, Cancer Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.12 | 3,537 | $89K | 50.3% |
| 2 | $26.20 | 3,350 | $88K | 49.7% |
| Total | $25.65 avg | 6,887 | $177K | 100% |
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |